Source: http://www.annalsofhealthlaw.com/annalsofhealthlaw/vol__26_issue_1?pg=87
Timestamp: 2019-04-19 10:13:55+00:00

Document:
104. 21 C.F.R. § 201.24 (2008).
105. Saver, supra note 30, at 466.
108. Barbara J. Evans, Seven Pillars of a New Evidentiary Paradigm: The Food, Drug, and Cosmetic Act Enters the Genomic Era, 85 NOTRE DAME L. REV. 419, 511–12 (2010).
110. 21 U.S. C. § 355-1(a)( 2)( A) (2008).
111. Fox, supra note 29, at 58.
112. 21 U.S. C. § 355-1(f)( 3)( A).
113. 21 U.S. C. § 355-1(f)( 3)( B).
114. 21 U.S. C. § 355-1(f)( 3)( C).
115. 21 U.S. C. § 355-1(f)( 3)( D).
116. 21 U.S. C. § 355-1(f)( 3)(E).
117. 21 U.S. C. § 355-1(f)( 3)(F).
118. Evans, supra note 109, at 512.

References: § 201
 § 355
 § 355
 § 355
 § 355
 § 355
 § 355
 § 355